IQVIA Holdings Inc. (IQV) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
IQV Revenue Growth
Revenue Breakdown (FY 2025)
IQV's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
IQV Revenue Analysis (2014–2025)
As of May 8, 2026, IQVIA Holdings Inc. (IQV) generated trailing twelve-month (TTM) revenue of $16.63 billion, reflecting solid growth of +8.4% year-over-year. The most recent quarter (Q1 2026) recorded $4.15 billion in revenue, down 4.9% sequentially.
Looking at the longer-term picture, IQV's 5-year compound annual growth rate (CAGR) stands at +7.5%, indicating steady revenue expansion. The company achieved its highest annual revenue of $16.31 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows IQV's business is primarily driven by Research And Development Solutions (55%), Technology And Analytics Solutions (41%), and Contract Sales And Medical Solutions (5%). With over half of revenue concentrated in Research And Development Solutions, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including CRL (+0.1% YoY), ICLR (-2.5% YoY), and PRA (-3.2% YoY), IQV has underperformed the peer group in terms of revenue growth. Compare IQV vs CRL →
IQV Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| IQVCurrent | $16.6B | +8.4% | +7.5% | 14.0% | |
 CRL | $4.0B | +0.1% | +6.5% | 12.6% | |
 ICLR | $8.3B | -2.5% | +24.2% | 13.3% | |
 PRA | $1.1B | -3.2% | +4.4% | 6.6% | |
 MEDP | $2.5B | +24.2% | +22.3% | 21.1% | |
 VEEV | $3.2B | +16.3% | +16.9% | 28.7% |
IQV Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $16.31B | +5.9% | $4.29B | 26.3% | $2.29B | 14.0% |
| 2024 | $15.40B | +2.8% | $5.38B | 34.9% | $2.20B | 14.3% |
| 2023 | $14.98B | +4.0% | $5.24B | 35.0% | $1.98B | 13.2% |
| 2022 | $14.41B | +3.9% | $5.03B | 34.9% | $1.80B | 12.5% |
| 2021 | $13.87B | +22.1% | $4.64B | 33.5% | $1.39B | 10.0% |
| 2020 | $11.36B | +2.4% | $3.86B | 34.0% | $731.0M | 6.4% |
| 2019 | $11.09B | +6.5% | $3.79B | 34.2% | $777.0M | 7.0% |
| 2018 | $10.41B | +7.3% | $3.67B | 35.2% | $741.0M | 7.1% |
| 2017 | $9.70B | +42.4% | $3.40B | 35.1% | $719.0M | 7.4% |
| 2016 | $6.82B | +18.8% | $2.07B | 30.3% | $642.0M | 9.4% |
Full IQV Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See IQV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IQV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IQV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIQV — Frequently Asked Questions
Quick answers to the most common questions about buying IQV stock.
Is IQV's revenue growth accelerating or slowing?
IQV maintains +8.4% revenue growth, in line with its 5-year CAGR of +7.5%. TTM revenue stands at $16.6B. Growth rate remains consistent with historical average.
What is IQV's long-term revenue growth rate?
IQVIA Holdings Inc.'s 5-year revenue CAGR of +7.5% reflects the sustained expansion pattern. Current YoY growth of +8.4% is near this long-term average.
How is IQV's revenue distributed by segment?
IQV reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.